Latest KFF Health News Stories
Podcast: KHN’s ‘What The Health?’ A Detour On A Smoking Off-Ramp
In this episode of KHN’s “What the Health?” Sarah Jane Tribble of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call talk about the Food and Drug Administration’s latest actions to address teenagers’ use of e-cigarettes, Arkansas’ Medicaid work requirements and news about the uninsured from the latest federal Census report.
Insurer To Purdue Pharma: We Won’t Pay For OxyContin Anymore
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
States Looking To Tax Opioids Pin Hopes On November Elections
At least 11 states are going to try to tax opioids despite pushback from pharmaceutical companies.
Giuliani’s Consulting Firm Helped Halt Purdue Opioid Investigation In Florida
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue’s marketing of OxyContin.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Suicide By Opioid: New Research Suggests Overdoses Should Be Classified As Self-Harm
Researchers combined the number of suicide deaths with those associated with drug overdoses in an effort to better grasp the overlap between these two public health epidemics.
Podcast: KHN’s ‘What The Health?’ Opioids, EpiPens And Health Funding
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?
Babies Dependent On Opioids Need Touch, Not Tech
One doctor in Kansas works to make sure every hospital in the state can provide the soft start, ideally with their mothers, that babies with neonatal abstinence syndrome need.
Purdue Pharma’s Sales Pitch Downplayed Risks Of Opioid Addiction
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
Podcast: KHN’s ‘What The Health?’ See You In Court!
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about a spate of lawsuits involving the Affordable Care Act, as well as the latest in state and federal efforts regarding the Medicaid program for the poor.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Clinicians Who Learn Of A Patient’s Opioid Death Modestly Cut Back On Prescriptions
A study published Thursday shows that doctors, dentists and other medical providers cut overall opioid dosages by nearly 10 percent after receiving notification of a death from a medical examiner and information on safe prescribing.
As Opioid Crisis Rages, Some Trade ‘Tough Love’ For Empathy
An approach known as Community Reinforcement and Family Training, or CRAFT, coaches families to deal with a loved one’s substance abuse with compassion.
Listen: Inexpensive Nerve Drug Often Abused As Opioid Epidemic Grows
Gabapentin, a medication approved to help patients with nerve pain or epilepsy, is being abused by people addicted to opioids to help prolong their high or stave off withdrawal from other drugs. Kaiser Health News reporter Carmen Heredia Rodriguez talks about the problem during a wide-ranging health discussion on the NPR program “On Point.”
How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers
Fentanyl and other painkillers marketed as safer than Purdue Pharma’s blockbuster drug left their own trail of overdose deaths.
Pacientes con dolor crónico se sienten atrapados en el debate sobre opioides
Los pacientes que necesitan esta medicación se sienten afectados injustamente por la tendencia a recetarlos cada vez menos, como una estrategia para frenar la creciente epidemia de abuso de opioides.
Patients With Chronic Pain Feel Caught In An Opioid-Prescribing Debate
States are passing laws that limit a doctor’s ability to prescribe opioids. Doctors and patients alike are wrestling with what that means in cases of chronic pain.
Readers And Tweeters: On Seniors Packing Heat And When They Should Pack It In
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Purdue Pharma Edits Public Service Ad In Washington Post
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed — then walk it back?
